agilon health, inc. (NYSE:AGL - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Friday . The company traded as low as $1.88 and last traded at $1.88, with a volume of 245464 shares changing hands. The stock had previously closed at $2.79.
Wall Street Analyst Weigh In
AGL has been the subject of several recent analyst reports. Citigroup restated a "sell" rating and issued a $2.50 target price (down previously from $7.00) on shares of agilon health in a research report on Tuesday, October 29th. William Blair cut agilon health from an "outperform" rating to a "market perform" rating in a research report on Friday. Deutsche Bank Aktiengesellschaft reduced their price target on agilon health from $5.00 to $4.00 and set a "hold" rating for the company in a research report on Friday, August 9th. Bank of America lowered agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price target on the stock. in a report on Wednesday, October 2nd. Finally, Evercore ISI lowered their target price on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a research note on Tuesday, October 8th. Three equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, agilon health presently has a consensus rating of "Hold" and a consensus target price of $7.81.
Check Out Our Latest Stock Report on agilon health
agilon health Price Performance
The stock has a 50 day moving average of $3.31 and a two-hundred day moving average of $5.00. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The stock has a market cap of $757.12 million, a PE ratio of -2.70 and a beta of 0.60.
agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the firm earned ($0.04) EPS. The firm's quarterly revenue was up 38.7% on a year-over-year basis. Equities analysts anticipate that agilon health, inc. will post -0.32 EPS for the current year.
Insider Activity
In other agilon health news, CEO Steven Sell acquired 20,000 shares of the firm's stock in a transaction on Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now owns 67,590 shares of the company's stock, valued at $227,102.40. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.20% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On agilon health
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. J.Safra Asset Management Corp increased its stake in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock worth $27,000 after acquiring an additional 3,625 shares during the last quarter. City State Bank acquired a new stake in shares of agilon health during the 3rd quarter valued at about $52,000. CWM LLC grew its stake in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after buying an additional 7,288 shares in the last quarter. Nisa Investment Advisors LLC acquired a new position in agilon health in the second quarter worth approximately $60,000. Finally, Bleakley Financial Group LLC acquired a new stake in agilon health in the first quarter valued at approximately $65,000.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.